Akums Drugs and Pharmaceuticals Limited IPO: Issue Price, Listing Gain and Share Price Now
Akums Drugs and Pharmaceuticals Limited listed on 06-Aug-2024 at ₹796.35 against an issue price of ₹679 , a listing gain of +17.28%. It last traded at ₹753.2. This page is the record of that issue and what has happened to it since — reported figures only.
Akums Drugs and Pharmaceuticals Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹679 |
| Listing price (listing-day close) | ₹796.35 |
| Listing gain | +17.28% |
| Price now | ₹753.2 |
| Change from issue price | +10.93% |
| Change from listing-day close | -5.42% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Akums Drugs and Pharmaceuticals Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹679 |
| Issue size | ₹1,856.74 Cr |
| Fresh issue | ₹680.99 Cr |
| Offer for sale | ₹1,175.75 Cr |
| Issue opened | 30-Jul-2024 |
| Issue closed | 01-Aug-2024 |
| Listed on | 06-Aug-2024 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | ICICI Securities (left lead) |
How the Akums Drugs and Pharmaceuticals Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 90.09x |
| NII | 42.10x |
| Retail | 20.80x |
| Total | 63.44x |
Akums Drugs and Pharmaceuticals Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹11,864 Cr |
| Trailing P/E | 38.90x |
| Return on capital employed | 14.9% |
| Return on equity | 8.4% |
| 52-week high | ₹775 |
| 52-week low | ₹409 |
| Sector | Pharmaceuticals |
Fundamentals are as of the desk's last harvest and move with the market.
- Akums Drugs and Pharmaceuticals Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.